Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor

@article{Plvimki2005InteractionsOS,
  title={Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor},
  author={E. -P. P{\"a}lvim{\"a}ki and Hannu Majasuo and Aki Laakso and Mikko Kuoppam{\"a}ki and Erkka Syv{\"a}lahti and Bryan L. Roth and Jarmo Hietala},
  journal={Psychopharmacology},
  year={2005},
  volume={126},
  pages={234-240}
}
Interactions of the selective serotonin reuptake inhibitors (SSRIs) citalopram, fluoxetine and its main metabolite norfluoxetine, and the tricyclic anti-depressant (TCA) imipramine with the rat serotonin 5-HT2C receptor in a clonal cell line and in the rat choroid plexus were investigated by radioligand binding and phosphoinositide (PI) hydrolysis assays. For comparison, the affinities of a variety of other antidepressants of different chemical classes for the cloned rat 5-HT2C and 5-HT2A… Expand
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
TLDR
It is suggested that sensitisation of 5-HT2C receptor-mediated intracellular signal transduction may play a role in the effects of citalopram, and may explain some of the pharmacodynamic differences seen with these drugs, especially upon repeated administration. Expand
Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
TLDR
Using in vivo microdialysis methods in rats, the nonselective 5-HT2 receptor antagonist ketanserin was observed to produce a robust augmentation of citalopram-, fluoxetine-, and sertraline-induced elevations of hippocampal extracellular serotonin levels. Expand
Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding
TLDR
The present survey compares the effects of antidepressants and their principal metabolites on reuptake of biogenic amines and on receptor binding to suggest that both dopaminergic and noradrenergic components play a role and that the hydroxybupropion metabolite contributes significantly to the antidepressant activity. Expand
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.
TLDR
There is evidence that stimulation of regionally discrete populations of 5-HT2C receptors is effective in certain behavioural models of antidepressant activity, and promotes neurogenesis in the hippocampus, which underpin interest in 5- HT2C receptor blockade as a strategy for treating depressive and anxious states. Expand
The genetics of selective serotonin reuptake inhibitors.
TLDR
It is concluded that serotonin transporter gene variation in humans affects the efficacy and side-effects of SSRIs, whereasSSRIs generally do not affect serotonin transporter genes expression in animals. Expand
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes
TLDR
The locomotor response to SSRIs of mice exposed to a novel environment is mediated via 5-HT1B and5-HT2A receptors, and the significance of these observations to the clinical actions ofSSRIs will be of interest to elucidate. Expand
Investigation of the SSRI augmentation properties of 5-HT2 receptor antagonists using in vivo microdialysis
TLDR
Results confirm recent findings that 5-HT(2) receptor antagonists augment the effect of citalopram on extracellular 5-hydroxytryptamine (5-HT) neurones, and indicate the involvement of 5- HT(2C) and possibly 5-ht(2A) receptors. Expand
Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain.
TLDR
In diabetic neuropathic rats, an alteration of the antihyperalgesic effect induced by stimulation of 5-HT2A receptors, which is known to mediate SSRI-induced analgesia, is shown. Expand
Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists
TLDR
Serotonin, as the natural ligand was chosen as reference compound to advance a hypothesis able to explain the receptor inhibition mechanism, and a different behavior between the antagonists and inverse agonist with respect to serotonin or unbounded receptor, which could be responsible for receptor’s inactivation. Expand
α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons
Abstract The aim of the present study was to investigate the modulation of locus coeruleus neurons by the selective serotonin (5-HT) reuptake inhibitor citalopram using single-unit extracellularExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 50 REFERENCES
Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.
TLDR
Results suggest that antagonism at brain 5-HT1C receptors is a component of the antiserotonergic properties of a number of established antidepressants. Expand
Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
The new antidepressant drugs, fluoxetine (and its enantiomers), citalopram, indalpine, paroxetine, and femoxetine show relatively weak affinities for 5-HT receptors as measured by radioligand bindingExpand
Pharmacological profile of binedaline, a new antidepressant drug.
TLDR
The results indicate that binedaline is comparable to a tricyclic antidepressant drug in inhibiting the norepinephrine uptake but, however, it is devoid of affinity for neurotransmitter receptors. Expand
Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
TLDR
Functional studies of 5-HT-stimulated phosphoinositide hydrolysis showed that ritanserin blocks the effect of5-HT and that it functions as a competitive antagonist of the 5- HT-1c receptor in intact choroid plexus. Expand
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
TLDR
5-HT2C receptor neutral antagonists exhibited functional and receptor binding properties consistent with those of classical receptor antagonists, however, 5-HT 2C receptor inverse agonists displayed functional and receptors binding properties that were opposite those of agonists. Expand
Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
TLDR
It is demonstrated that clozapine and one of its major metabolites in man, N-desmethylclozapines, are potent 5-HT1C receptor antagonists. Expand
Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs
TLDR
This study characterized the interaction of chlorpromazine (CPZ) and three putative atypical antipsychotic drugs, risperidone (RIS), amperozide (AMP), and ORG 5222 (ORG), and found that 5-HT2A and 5- HT2C receptors are differentially regulated after chronic treatment with CLOZ, CPZ, RIS, AMP, and OrG. Expand
Chronic Citalopram and Fluoxetine Treatments Upregulate 5-HT2C Receptors in the Rat Choroid Plexus
TLDR
The results show that chronic citalopram and fluoxetine treatments induce an increase of choroid plexus 5-HT2C receptor density, but the effect is more marked with citalsopram. Expand
Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
TLDR
Observations indicate that guanine nucleotide-binding protein (G protein)-coupled receptors can exhibit high affinity for neurotransmitters in both the free receptor and the G protein- coupled states and that receptors exhibiting this property may represent a novel subfamily of G protein. Expand
Fluoxetine: A Serotonin‐specific, Second‐generation Antidepressant
TLDR
Fluoxetine is a bicyclic antidepressant that is a specific and potent inhibitor of the presynaptic reuptake of serotonin that has been used with success in obsessive‐compulsive disorder and intention myoclonus, however, its use in these disorders remains investigational. Expand
...
1
2
3
4
5
...